Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
about
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian responseIndividualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceAnimal models of the polycystic ovary syndrome phenotypeAnti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsAMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisClinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysisGenome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populationsInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheepIdentification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSHFollicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSHPhase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation inductionPrognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolPrestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins.Mild ovarian stimulation for IVF: 10 years later.Demographic characteristics and clinical profile of poor responders in IVF / ICSI: A comparative study.The role of anti-Müllerian hormone in female fertility and infertility - an overview.The luteinizing hormone beta-subunit exon 3 (Gly102Ser) gene mutation and ovarian responses to controlled ovarian hyperstimulationInvestigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulationSerum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunityMeasurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulationIndividualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?Oocyte-derived R-spondin2 promotes ovarian follicle development.Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes.Approaches to improve the diagnosis and management of infertilityImproving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.Graded response to short photoperiod during development and early adulthood in Siberian hamsters and the effects on reproduction as females ageAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Altered Circulating Inflammatory Cytokines Are Associated with Anovulatory Polycystic Ovary Syndrome (PCOS) Women Resistant to Clomiphene Citrate Treatment.Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF.Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation.Use of metformin in the treatment of polycystic ovary syndrome.
P2860
Q24289192-718D2417-7107-45C4-8D4A-FB9FAC2A51F4Q26829747-A4984526-5F4D-4281-AB7D-1E22154FC99DQ27024884-4BDDC5F8-701D-47E5-984F-31F03BB82945Q28239980-8676A5A7-15DD-41DC-A98B-567F7DB7FAFAQ28289118-A6871D11-454A-4960-9966-5361134C660EQ28293370-25FFE9DC-7D8A-4E6F-A71D-63170B5F523DQ30370866-C863717F-DF28-487E-B73A-14ECAF9BEA7BQ33569169-1963EFD7-9B3D-4BD8-B412-7CBBC9A72256Q33583733-76FFC306-94CA-4A3A-ACC6-9AC99691531AQ33736105-DF819C22-F84A-4D8B-8570-57858425F7E3Q33810850-3AE31252-32F3-4A8C-A23B-E5496F56B44DQ33881072-3F2E36E0-84E1-413B-8243-82B05F98F5D9Q33888265-28A62FB0-3302-4B39-B86D-6FA1F191346BQ34008036-93720975-093A-4CB4-BD15-20B076FF4880Q34139320-1637CBCD-36F5-4D92-81AF-888ADAD204F8Q34268692-2D5D6C6A-0E69-4B85-B401-6AFD123AB661Q34278051-D6DA26EF-6CEA-4AFE-9506-05DBBB6BD2F4Q34589525-9A8F1E89-A304-4E22-BCD5-363381116471Q35493479-801C70BC-2671-4BA0-A89D-3AF8F3BEA453Q35621462-4F4759E5-76C9-44DD-AF72-816167A39E8AQ35769428-132C188A-974A-429D-A66D-AF6AE298D9DDQ35898934-A89CB6A6-E33F-485D-BEB8-DAE19DEF4B91Q36082015-E34E96CE-0E1F-49D2-9369-E13479D4C0B9Q36192094-3C8A695D-EB22-4CAD-AC0C-A6ED47AF3CC4Q36234933-7F89C7B3-8381-44AF-B16F-CD196F7B84C5Q36309513-91A304FE-8B46-42E3-B3C6-CC004F8A0EE2Q36594368-2AA22944-727C-4B6A-8116-DE5303097500Q36599421-F034EF37-71AB-4712-A74A-A43471611FE2Q36815697-7BB62F63-9A5E-48DB-96EF-DC6235ECFCF8Q36860325-1BC54A66-289E-41F6-8A9C-EFFE9AD90C0EQ36907318-7568752F-CB60-409C-8CE8-E19FFF460D43Q37077680-B3243B17-2958-4223-BD7A-DF23C5E51EB6Q37214916-62A60AFC-215C-4F69-AD5A-C217DF11B520Q37372180-8216FA8C-D184-4411-9DB3-3E802DAA83B8Q37437972-EE9D1D41-580B-40D5-8C68-89668750E009Q37606149-1CF74DDF-ECBB-406D-B9C0-1E92D5D2A101Q37691476-BF60C6C5-2871-4A33-89FD-F93469F1A74DQ37698619-0C42B3D4-3415-4C24-9F43-1043906A3AAFQ37716656-0525C075-95C8-4A69-8A4D-8B2787B8B408Q37769526-D6F0481F-ACED-4611-BA89-8617BEB781E1
P2860
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Predictors of ovarian response ...... ction and ovarian stimulation.
@en
Predictors of ovarian response ...... ction and ovarian stimulation.
@nl
type
label
Predictors of ovarian response ...... ction and ovarian stimulation.
@en
Predictors of ovarian response ...... ction and ovarian stimulation.
@nl
prefLabel
Predictors of ovarian response ...... ction and ovarian stimulation.
@en
Predictors of ovarian response ...... ction and ovarian stimulation.
@nl
P2093
P356
P1476
Predictors of ovarian response ...... ction and ovarian stimulation.
@en
P2093
B C J M Fauser
Evian Annual Reproduction Workshop Group 2007
K Diedrich
P356
10.1093/HUMUPD/DMM034
P50
P577
2007-11-15T00:00:00Z